Navigation Links
Science in Society Journalism Award winners announced
Date:9/17/2010

The winners of the 2010 Science in Society Journalism Awards, sponsored by the National Association of Science Writers, are:

  • In the Book category, Susan Cohen and Christine Cosgrove for "Normal at Any Cost: Tall Girls, Short Boys, and the Medical Industry's Quest to Manipulate Height" (Tarcher/Penguin).

  • In the Science Reporting category, a tie between entries from the Associated Press and the New York Times. Martha Mendoza and Margie Mason won for their Associated Press series "When Drugs Stop Working," and Charles Duhigg won for his New York Times series "Toxic Waters."

  • In the Local or Regional Science Reporting category, J. Madeleine Nash for her article "Bring in the Cows," which appeared in High Country News.

Winners in each category will share a cash prize of $2,500, to be awarded at a reception on November 7, 2010 during the ScienceWriters2010 meeting, taking place this year in New Haven, Connecticut.

NASW established the Science in Society awards to provide recognition -- without subsidy from any professional or commercial interest -- for investigative or interpretive reporting about the sciences and their impact on society. The awards are intended to encourage critical, probing work that would not receive an award from an interest group. Beginning with the first award in 1972, NASW has highlighted innovative reporting that goes well beyond the research findings and considers the associated ethical problems and social effects. The awards are especially prestigious because they are judged by accomplished peers. NASW currently awards prizes in four categories: Books, Science Reporting, Science Reporting with a Local or Regional Focus, and Commentary or Opinion .

The judges chose not to make an award in the Commentary or Opinion category this year.

  • In "Normal at Any Cost," Cohen and Cosgrove tell the history of medical attempts to alter height in children. I
    '/>"/>

Contact: Tinsley Davis
director@nasw.org
510-647-9500
National Association of Science Writers
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. High testosterone levels linked to self-destructive CEO behavior, says Management Science
2. UT Health Science Center San Antonio lands $11.6 million to study cardiac proteins
3. You say, bio-math, I say, math-bio: Crossing science education divide
4. GEN reports on the greening of the life sciences
5. 23rd ECNP Congress: Pioneering CNS research -- translating neuroscience into clinical progress
6. Human cells can copy not only DNA, but also RNA, says team from Pitt, Helicos BioSciences
7. Social ecology: Lost and found in psychological science
8. Supercomputers take science by storm
9. Biology, computer science combine efforts to fight cancer
10. Stanford engineers use rocket science to make wastewater treatment sustainable
11. Getting young scientists into the science teacher pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2015)... , Aug. 19, 2015  VOXX International Corporation ... has entered into a Definitive Agreement to purchase ... iris authentication market leader EyeLock through an acquiring ... have a controlling interest in the acquiring entity. ... completion of due diligence.  Expanding on its existing ...
(Date:8/12/2015)... As the digital payment services ... advanced biometrics technology is accelerating beyond expectations.  While the ... using their credit cards, the digital currency, mobile payment ... services led by companies in the space such as ... (NASDAQ: GOOG ), Apple Inc. (NASDAQ: AAPL ...
(Date:8/10/2015)... , August 10, 2015 The latest ... offers comprehensive analysis of the global border security market ... revenues of $16.4bn in 2015. Now: Border security ... an example of the business critical issue you need to ... visiongain ,s objective analysis of how this will impact ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 2Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 4Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 5Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 7Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 8Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 9
... California pistachios took center stage at this year,s American ... (FNCE), the industry,s premier conference where thousands of registered ... emerging health trends. Pistachios led with ... of mindful eating and, for the first time ever, ...
... A monoclonal antibody targeting a well known cell surface ... aggressive form of the disease that did not respond ... with the UCLA Department of Urology and UCLA,s Jonsson ... the protein, N-cadherin, is up regulated or turned on ...
... found that women who receive silicone implants after a double ... receive saline implants. Published early online in CANCER , ... may help physicians and breast cancer survivors as they together ... have one or both of their breasts removed as a ...
Cached Biology News:California pistachios: Dietitian and Mother Nature approved 2California pistachios: Dietitian and Mother Nature approved 3UCLA researchers discover a potential target for therapy for patients with a deadly prostate cancer 2UCLA researchers discover a potential target for therapy for patients with a deadly prostate cancer 3Breast cancer patients prefer silicone over saline implants after mastectomy 2
(Date:9/2/2015)... ... September 02, 2015 , ... ... to creating professional commercial video content, to analysis of athletic performance. Producing ... that go by too quickly to process with the naked eye. , ...
(Date:9/1/2015)... , Sept. 1, 2015 The American ... Intent (LOI) for its Discovery Research Grant program. LOIs ... at 12:00 noon CDT. Discovery Grants ... with the potential to change current diagnostic or treatment ... grants specifically encourage novel research at its earliest stages, ...
(Date:9/1/2015)... ... ... In her thought provoking debut novel ‘ Ebola Vaccine Wars ’ (eBookIt.com; ... an Ebola pandemic that is on the cusp of wiping out humanity. Venice introduces ... counterterrorism, and who continues to appear in this series of books by Venice. ...
(Date:9/1/2015)... MA (PRWEB) , ... September 01, 2015 , ... ... top biopharmaceutical companies in the neuro and pain management space join prominent academics ... B. Martin Conference Center at Harvard Medical School in Boston. , Neuro ...
Breaking Biology Technology:Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3American Brain Tumor Association Seeks Innovative Concepts For Discovery Research Grants 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 3Neuro Advance Boston Brings Together Leading Neuroscience Experts on October 14 at Harvard Medical School 2
... Permitted to Enroll in 2nd and 3rd ... Eliminated, SAN DIEGO, Dec. 13 Arena ... initiation of patient screening in,the second and third ... of its lead drug candidate, lorcaserin hydrochloride, for ...
... Dec. 13 /PRNewswire-FirstCall/ - MIGENIX Inc.,(TSX: MGI; ... for infectious,diseases, reports financial results for the ... update on its programs., UPDATE ON ... (Omigard(TM)/CPI-226/MX-226; topical cationic peptide;,prevention of catheter-related infections): ...
... Announced Details of a Planned Phase II Study of ... Relapsing Remitting Multiple Sclerosis, COPENHAGEN, Denmark, December 13 ... planned Phase II study of,ofatumumab (HuMax-CD20(R)) for the treatment ... be enrolled in,the study which will be conducted under ...
Cached Biology Technology:Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 2Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 3Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 4Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 5Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 6MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 2MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 3MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 4MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 5MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 6MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 7MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 8MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 9MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 10MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 11MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 12MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 13MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 14MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 15MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 16MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 17MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 18Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 3
... Hybaid's unique Electro-4 design allows "4 gels ... it is possible to run 200,samples or ... stacking up to four,horizontal gels. To ensure ... to the number of gels being run. ...
... Continuing a tradition of progressive centrifuge design ... series. The Centra-CL3 and Centra-CL3R (refrigerated) general ... laboratory., Quality Control Over Sample Preparation ... lock up to 99 protocols and has ...
... DNA Polymerase I Large (Klenow) Fragment, Exonuclease ... lacks both the 5´→3´ and the 3´→5´ ... DNA Polymerase I (1,2). It is used ... strand displacement amplification (5). Klenow Fragment, Exonuclease ...
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
Biology Products: